K. Michalko

发表

An Evaluation of a Clinical Pharmacokinetic Service for Serum Digoxin Levels

K. Michalko, L. Blain, 1987, Therapeutic drug monitoring.

Daily maintenance dose of a long-acting theophylline from a single theophylline serum level.

J. Thiessen, N. Dayneka, R. Goldstein, 1986, Chest.

Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.

K. Michalko, Graeme Donnelly, Joseph L. Reiz, 2008, Clinical therapeutics.

More on cephalosporin interference with creatinine determinations.

K. Michalko, L. C. Allen, C. Coons, 1982, Clinical chemistry.

Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study.

I. Sutton, J. Eisenhoffer, M. Csanádi, 2013, Pain research & management.

Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase.

S. Rashiq, A. Gordon, N. Buckley, 2010, Clinical therapeutics.

The Pain and Sleep Questionnaire three-item index (PSQ-3): a reliable and valid measure of the impact of pain on sleep in chronic nonmalignant pain of various etiologies.

L. Ayearst, Z. Harsanyi, K. Michalko, 2012, Pain research & management.

Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients.

B. Setnik, Z. Harsanyi, P. Geoffroy, 2016, Journal of Opioid Management.

Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses

D. W. Bryant, D. R. McCalla, J. Heddle, 1990, Environmental and molecular mutagenesis.